Early hydroxyurea use is neuroprotective in children with sickle cell anemia
- PMID: 35836401
- DOI: 10.1002/ajh.26664
Early hydroxyurea use is neuroprotective in children with sickle cell anemia
Abstract
Children with sickle cell disease (SCD) who began hydroyxurea before age five years scored no differently on a measure of cognitive funciton than age, sex, and race-matched unaffected peers.
© 2022 Wiley Periodicals LLC.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
